Presentation
7 March 2022 Applying label free imaging to GSK drug discovery projects: current successes and future opportunities
Author Affiliations +
Abstract
The ability to study drug distribution in real time, without disrupting the biological milieu and structure, has become a cornerstone of modern pharmaceutical development. GSK has developed a portfolio of these methods and this work is often performed in collaboration with academic partners within our Bioimaging Expertise Network (BEN). This presentation will review the successes achieved through this approach, highlighting recent advances; outline project specific case studies and demonstrate the integration of the data into drug development decisions. Finally, the current major challenges will be discussed as new opportunities for imaging collaboration.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Steve R. Hood and Aneesh Alex "Applying label free imaging to GSK drug discovery projects: current successes and future opportunities", Proc. SPIE PC11938, Visualizing and Quantifying Drug Distribution in Tissue VI, PC1193802 (7 March 2022); https://doi.org/10.1117/12.2606230
Advertisement
Advertisement
KEYWORDS
Drug development

Drug discovery

Tissue optics

Monoclonal antibodies

Monoclonal antibody therapy

Network security

Nonlinear optics

Back to Top